Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire
164 Leser
Artikel bewerten:
(0)

SRV Yhtiöt Oyj: SRV to launch construction work on new Siltasairaala Hospital for HUS

Helsinki, Finland, 2018-01-05 10:00 CET (GLOBE NEWSWIRE) --
SRV GROUP PLC                               INVESTOR NEWS                      
               5 JANUARY 2018, AT 11.00 

SRV to launch construction work on new Siltasairaala Hospital for HUS

The Hospital District of Helsinki and Uusimaa HUS has made the decision to
launch the implementation phase of the Siltasairaala Hospital in collaboration
with SRV. The construction site of the Siltasairaala Hospital, the largest
construction project in the history of HUS, will start up in early 2018. In
connection with the Siltasairaala Hospital, a separate investment project
comprising radiotherapy devices (linear accelerators 7, 8, and 14) will also be
implemented for the client. According to the project's target timetable
prepared in the development phase, construction work is due to be completed in
June 2022 and the hospital and the radiotherapy device facilities to be taken
into use in 2023. 

The new building will be constructed at Meilahti in Helsinki, in the centre of
the emergency hospital area. The Siltasairaala Hospital will provide patients
with high quality care in an attractive, safe, accessible and environmentally
friendly setting. It will replace the Töölö Hospital, which is in poor
condition, as well as part of the Department of Oncology building, combining
functions in the same campus. The Siltasairaala Hospital will be located
between the Meilahti Tower Hospital and the current Department of Oncology
building. These, together with the Meilahti Triangle Hospital, will then form
an integrated complex both operationally and in terms of healthcare premises. 

The scope of the project in terms of gross floor area is approximately 71,500
m2, including the hospital and the radiotherapy facilities. The number of
floors of the hospital will vary from five floors in the lowest part of the
complex to nine floors in the highest part. Among other things, the hospital
will have 215 beds in four wards, 58 intensive care unit beds, 69 day-hospital
treatment places, 16 operating theatres, outpatient clinics, a restaurant, and
lecture and teaching premises. 

The project management contractor agreement for the Siltasairaala Hospital was
signed in June 2017, at which time a development phase that lasted until the
end of the year was launched. Through the decision now made to launch the
implementation phase, the Siltasairaala Hospital project will be entered into
SRV's order backlog, with a target budget of EUR 243 million. The Siltasairaala
Hospital project further strengthens SRV's current position as Finland's
largest builder of hospitals and healthcare projects. HUS is investing EUR 295
million in the hospital construction project. The investment for the separate
linear accelerator 7, 8 and 14 project, to be implemented in the same complex,
is valued at EUR 17 million. The projects will be implemented as a joint
project management contract. 

In recent years, SRV and HUS have collaborated in the implementation of a
number of other projects, including an additional emergency unit at Jorvi
Hospital in Espoo and the renovation and extension of the 'L' section of the
Women's Hospital in Helsinki. SRV also has other significant hospital projects
under way, such as the new Hospital Nova in Jyväskylä and the new building
project at TAYS University Hospital in Tampere. The HUSLAB laboratory building
at Meilahti was completed significantly ahead of schedule and as an error-free
delivery in June 2015. Most recently, a new health and wellness centre,
completed at Kalasatama in Helsinki, was handed over to the client in October
2017, and it will be taken into use in February 2018. 

"The Siltasairaala Hospital agreement is an excellent addition to an already
strong hospital and wellness construction portfolio. The combined value of all
of SRV's current hospital project agreements is still approximately EUR 830
million, even after the completion of the Kalasatama health and wellness
centre. The Siltasairaala Hospital is being built by our top professionals, who
have strong experience of constructing healthcare premises and other demanding
special facilities, such as the New Children's Hospital, which is being built
close by to the Siltasairaala Hospital. SRV's role in society is in many ways
culminated in the hospital projects, and we aim to improve quality of life
through sustainable solutions for the built environment," says SRV's President
& CEO, Juha Pekka Ojala. 

"The Siltasairaala Hospital will complement the Meilahti campus as a demanding
specialised complex that enables the examination and care of patients in all
specialist medical care fields 24/7. Although the Siltasairaala Hospital will
have many premises containing very demanding technology, the hospital will be a
humane setting for patients, enabling individual needs to be taken into
account," explains HUS Project Director Raija Malmström. 

For further information , please contact:

Juha Pekka Ojala, President & CEO, SRV, tel. +358 40 733 4173, jp.ojala@srv.fi
Päivi Kauhanen, Senior Vice President, Communications, SRV, tel. +358 50 598
9560, paivi.kauhanen@srv.fi 
www.srv.fi

Raija Malmström, Project Director, HUS, tel. +358 50 428 6730,
raija.malmstrom@hus.fi 
www.hus.fi

www.srv.fi/tyomaa/siltasairaala

You can also find us on the social media:
Facebook   LinkedIn   Twitter   Instagram

SRV - Building for life
Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2018 GlobeNewswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.